FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+4.99%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$1.11B
AUM Growth
+$1.11B
(-2.2%)
Cap. Flow
+$21.9M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
85.85%
Holding
31
New
5
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
|
$8.59M |
| 2 |
Regenxbio
RGNX
|
$4.79M |
| 3 |
Cardiff Oncology
CRDF
|
$3.69M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$2.96M |
| 5 |
Minerva Neurosciences
NERV
|
$1.75M |
Top Sells
| 1 |
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
|
$306K |
Sector Composition
| 1 | Healthcare | 96.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
26
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.16M | 0.19% |
202,803
| – | – |
|
27
vTv Therapeutics
VTVT
$49.4M
| $1.88M | 0.17% |
1,062,000
| – | – |
|
|
28
Minerva Neurosciences
NERV
$16.8M
| $1.75M | 0.16% |
+550,000
| New | +$1.75M |
|
29
Iterum Therapeutics
ITRM
$28.1M
| $1.62M | 0.15% |
1,538,316
| – | – |
|
|
BLCM
30
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $691K | 0.06% |
105,144
| – | – |
|
|
ETTX
31
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $408K | 0.04% |
199,953
-150,000
| -43% | -$306K |
|